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Aswe age, our tissues are repeatedly challenged bymutational insult, yet cancer occurrence is a relatively rare
event. Cells carrying cancer-causing geneticmutations competewith normal neighbors for space and survival
in tissues. However, themechanisms underlyingmutant-normal competition in adult tissues and the relevance
of this process to cancer remain incompletely understood. Here, we investigate how the adult pancreasmain-
tains tissue health in vivo following sporadic expression of oncogenicKras (KrasG12D), the key drivermutation
in human pancreatic cancer. We find that when present in tissues in low numbers, KrasG12Dmutant cells are
outcompeted and cleared from exocrine and endocrine compartments in vivo. Using quantitative 3D tissue
imaging, we show that before being cleared, KrasG12D cells lose cell volume, pack into round clusters,
and E-cadherin-based cell-cell adhesions decrease at boundaries with normal neighbors. We identify
EphA2 receptor as an essential signal in the clearance of KrasG12D cells from exocrine and endocrine tissues
in vivo. In the absence of functional EphA2, KrasG12D cells do not alter cell volume or shape, E-cadherin-
based cell-cell adhesions increase and KrasG12D cells are retained in tissues. The retention of KRasG12D
cells leads to the early appearance of premalignant pancreatic intraepithelial neoplasia (PanINs) in tissues.
Our data show that adult pancreas tissues remodel to clear KrasG12D cells and maintain tissue health. This
study provides evidence to support a conserved functional role of EphA2 in Ras-driven cell competition in
epithelial tissues and suggests that EphA2 is a novel tumor suppressor in pancreatic cancer.
INTRODUCTION
Epithelial homeostasis is fundamental to survival and is required
to balance the number and fitness of cells that contribute to tis-
sue function. Homeostasis is maintained through distinct pro-
cesses that dynamically maintain this equilibrium in response
to tissue crowding,1 damage,2 or mutational insult.3–10 Retention
of excess, mutant, or aberrant cells would impair tissue integrity
and promote disease.11–13 The mechanisms underlying these
processes are multifaceted and involve cell competition,14 me-
chanical cues,15 and cell plasticity.16 Epithelial cells expressing
oncogenes compete for space and survival in tissues and are
often eliminated via processes that require the presence of
normal cells; however, the mechanisms underlying how normal
cells sense and eliminate mutant cells remain incompletely un-
derstood. We recently identified differential EphA2 signaling as
a novel, evolutionary conserved mechanism that drives the
segregation and elimination of RasV12 cells in simple
epithelia.10,17 EphA2 is a receptor tyrosine kinase of the Eph-
ephrin family of cell-cell communication signals that play a gen-
eral role in regulating cell proliferation and survival and cell-cell
adhesion at tissue boundaries, leading to the compartmentaliza-
tion of cells.18 Whether EphA2 is a general regulator of mamma-
lian tissue homeostasis in vivo is currently unknown.
The pancreas is composed of functionally distinct compart-
ments of epithelial cells derived from common progenitors.19
Exocrine acinar cells produce and secrete digestive enzymes
that travel to the gut via ductal networks. Endocrine cells of the
islets of Langerhans produce and secrete hormones that regu-
late blood glucose. Pancreatic cancer arises from activating
mutations in oncogenic Kras, and the majority (90%) of human
pancreatic tumors develop sporadically from cells carrying
KRAS mutations;20 however, KRasG12D mutations alone
are insufficient to drive malignancy.21,22 Pancreatic ductal
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adenocarcinoma (PDAC; the most common form of human
pancreatic cancer) develops predominantly from pancreatic in-
traepithelial neoplasia (PanIN).23 The cancer cell of origin in
PDAC remains controversial; however, in vivo mouse studies
indicate that tumorigenesis can develop from cells of exocrine
acinar, ducts, and endocrine lineages.24,25 Unlike rapidly prolif-
erating epithelia such as intestine or skin, the adult pancreas is
not actively renewing, has limited proliferative capacity during
homeostasis, and relies on cell plasticity to regenerate in
response to injury.26 What is less understood is how the adult
pancreas maintains tissue health following mutational insult.
Here, we set out to address this question and investigate the
requirement of EphA2 in adult pancreas following sporadic,
sparse induction of KrasG12D-expressing cells in vivo, recapitu-
lating a scenario of sporadic tumorigenesis. Using fluorescence
imaging of murine pancreas tissues and quantitative image anal-
ysis platforms, we demonstrate that KrasG12D cells are actively
cleared from the adult pancreas over time and in an EphA2-
dependent manner. In the absence of functional EphA2, mutant
cells are retained, accelerating premalignant lesion formation
and suggesting that EphA2-driven competition is tumor
suppressive.
RESULTS
Sparse KrasG12D mutant cells are lost from adult
pancreas tissues over time
We used the pancreas-specific Pdx1-CreERT LSL-KrasG12D/+;
Rosa26LSL-tdRFP (KC; red fluorescent protein [RFP]) mouse and
administered a single low dose of tamoxifen to induce Pdx1-
Cre recombinase in a low number of cells in an otherwise
normal epithelium. Experimental controls were Pdx1-CreERT;
Rosa26LSL-tdRFP (Kras wild type [WT]; control). This approach
generated tissues mosaic for Kras (and RFP) expression; sto-
chastic RFP labeling was induced in endocrine and exocrine
acinar and ductal lineages at low frequency (Figure 1A), 20%
of tissue (Figure S1A). In contrast, the administration of a high
dose of tamoxifen resulted in RFP expression in 80% of the
tissue (Figure S1A). RFP labeling was comparable in Kras WT
and KrasG12D tissues at 7 days post-induction (p.i.) (Figures
1B and 1C). We observed minimal variation in the levels of
recombination when sampling from the tail, middle, or head of
the pancreas (Figure S1B).
Based on our previous studies,22 we reasoned that putative
competition between KrasG12D and normal cells in adult tissues
would occur over protracted time points. We chose 35 days p.i.
as an endpoint andmonitored the amount of RFP fluorescence in
tissues over time. We found that the proportion of RFP+ tissue
did not significantly change between 7 and 35 days p.i. in control
animals (Figures 1B, upper panels, p = 0.092, and 1C). In
contrast, RFP fluorescence significantly decreased over time in
KrasG12D tissues (Figures 1B, lower panels, p < 0.002, and
1C), suggesting that KrasG12D cells are cleared from adult tis-
sues over a 4-week period. To validate these findings at the ge-
netic level, we analyzed relative levels of recombined RFP in
genomic DNA isolated from pancreas. Consistently, we found
that the relative amount of recombined RFP in genomic DNA
significantly decreased in KrasG12D tissues (p = 0.024; Fig-
ure 1D), whereas levels of recombined RFP remained constant
in Kras WT controls (p = 0.13; Figure 1D). Crucially and in
contrast to that observed in developing tissues,22 the proportion
of RFP+ tissue remained unchanged over time in adult KrasG12D
tissues treated with high-dose tamoxifen (Figures S1C, lower
panels, p = 0.5, and S1D), suggesting that the selective loss of
RFP+ cells from adult KrasG12D tissues is not cell autonomous
and requires the presence of normal cells. Consistent with previ-
ous reports,11 RFP+ ducts were significantly less frequent in
KrasG12D tissues compared to Kras WT controls (p = 0.04; Fig-
ure 1E). The number of RFP+ islet cells also significantly
decreased over time in KrasG12D tissues (p = 0.0008; Figure 1F).
Since exocrine acinar cells are predominately labeled with RFP
(Figure 1A), we conclude that KrasG12D cells are outcompeted
by normal cells in all epithelial compartments in adult pancreas
in vivo.
KrasG12D mutant cells are outcompeted in an EphA2-
dependent manner
To determine themechanisms underlying KrasG12D cell compe-
tition, we monitored tissue homeostasis by scoring cell prolifer-
ation and cell death events in fixed tissues. Using TUNEL assays
(Figure S2A) and immunostaining for cleaved caspase 3 (Fig-
ure S2B), we found that apoptosis events were extremely rare
in both KrasG12D and Kras WT tissues, and we found no bias
in the localization of rare apoptotic cells to RFP+ cells (not
shown). Apoptotic events remained unchanged over time
regardless of genotype (p > 0.1; Figure S2B), suggesting that
KrasG12D cells are not triggered to die by apoptosis. We found
no evidence of cell senescence in tissues (data not shown). The
number of Ki67+ cells per tissue area significantly decreased
over time in both Kras WT tissues and KrasG12D (p < 0.004; Fig-
ure S2C). This is consistent with reports that cell proliferation de-
creases in aging pancreas tissues over time,27,28 and it implies
that changes in cell proliferation rates are unlikely to contribute
to the clearance of KrasG12D cells from KC tissues.
Based on our previous work,10,17 we asked whether EphA2 is
required to promote the clearance of KrasG12D cells from adult
pancreas tissues in vivo. We crossed KC animals onto EphA2
knockout mice, generating Pdx1-CreERT; LSL-KrasG12D/+;
Rosa26LSL-tdRFP; Epha2/ mice (referred to as KCE). Pdx1-
CreERT; Rosa26LSL-tdRFP; Epha2/ (EphA2/ control) animals
were included as controls. Mice homozygous for the targeted
EphA2mutation are deficient for EphA2 protein29 and are there-
fore knockout for EphA2. By comparing the amount of RFP fluo-
rescence in 7-day tissues, we found no significant difference in
the level of recombination between different cohorts (p = 0.15,
EphA2/ versus Kras WT control; p = 0.34, KrasG12D
EphA2/ versus KrasG12D). Similar to Kras WT control tissues,
we observed that the proportion of RFP+ tissue did not signifi-
cantly change in EphA2/ control tissues over time (Figures
2A, top panels, p = 0.57, and 2B). Notably and in contrast to
KrasG12D tissues (Figures 1B–1D), RFP fluorescence was not
significantly different over time in KrasG12D EphA2/ tissues
(Figures 2A, lower panels, p = 0.29, and 2B; KrasG12D
EphA2/), indicating that RFP+ KrasG12D cells are not cleared
from tissues depleted of EphA2. Moreover, KrasG12D EphA2/
and EphA2/ control 7-day tissues contained similar numbers
of RFP+ ducts (p = 0.53; Figure 2C), further indicating that
KrasG12D cells are cleared from ductal epithelial tissues at
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very early time points. Notably, the number of RFP+ ducts was
significantly increased in KrasG12D EphA2/ tissues compared
toKrasG12D tissues (p = 0.028; compare Figure 2C to Figure 1E).
RFP+ islets also significantly increased in KrasG12D EphA2/
tissues over time (p = 0.0035; Figure 2D). We observed no signif-
icant difference in the number of cleaved caspase-3+ cells over
time in KrasG12D EphA2/ tissues (p = 0.18; Figure S2D); how-
ever, apoptotic events were significantly higher in younger
EphA2/ tissues (p = 0.021), indicating that EphA2 signaling
prevents apoptosis, which is consistent with previous reports.30
Cell proliferation events significantly decreased in aging
KrasG12D EphA2/ tissues (p = 0.0035) and in aging EphA2/
controls (p = 0.045; Figure S2E), similar to that observed in
KrasG12D or KrasWT tissues. We conclude that KrasG12D cells
are outcompeted from all tissue compartments in an EphA2-
dependent manner and independent of changes in global cell
proliferation/cell death. Moreover, KrasG12D cells are retained
in EphA2-depleted tissues.
KrasG12D cells shrink and form tightly packed round
clusters in an EphA2-dependent manner
Competitive interactions with normal cells induce RasV12 cells
to adopt a contractile morphology and segregate from normal
neighbors.4,10,17 To gain insight into KrasG12D cell fate in vivo,
we examined KrasG12D cell morphology in fixed pancreas tis-
sues using immunofluorescence tomography (IT)31,32 and
quantitative image analysis. Fixed serial tissue sections were
immunolabeled for E-cadherin and RFP, imaged by confocal
microscopy and aligned and stacked to generate 3D recon-
structions (Video S1). Individual cells were segmented based
on E-cadherin staining. Using internuclear distance measure-
ments between cells in direct contact10 and circularity as a
readout of cluster roundness, we found that RFP+ acinar cells
formed significantly more compact (p < 0.0001; Figure 2E)
and round (p = 0.0072; Figure 2F) clusters in 7-day KrasG12D
tissues compared to Kras WT controls. In addition, RFP+ acinar
cells significantly decreased in cell volume in KrasG12D tissues
A B C
D E F
Figure 1. RFP-labeled KrasG12D cells are cleared from pancreas tissue compartments in vivo
(A) Pancreas tissue (Kras WT) fixed at 7 days p.i. and stained with anti-RFP (red), anti-E-cadherin (green) antibodies, and Hoescht (blue). White arrows, RFP-
labeled acinar cells; white arrowhead, RFP-labeled ductal epithelial cells; dashed white line, RFP-labeled islet.
(B) RFP fluorescence in tissues harvested from Kras WT (control) or KrasG12D mice. Scale bars, 500 mm.
(C) Percentage RFP fluorescence/tissue area over time. Each data point represents average RFP fluorescence per mouse. **p < 0.002, unpaired Student’s t test
using Welch correction. Kras WT controls, n = 5 mice (7, 35 days); KrasG12D, n = 4 (7 days), n = 6 mice (35 days).
(D) RFP expression in genomic DNA relative to housekeeping gene/tissue/mouse. *p = 0.024, unpaired Student’s t test usingWelch correction; n = 5 (7 days); n = 6
(35 days) mice/genotype.
(E) Percentage RFP+ ducts in Kras WT control and KrasG12D tissues over time. Data are means ± SEMs. *p = 0.04, one-way ANOVA. Kras WT controls, n = 8
(7 days), n = 5 mice (35 days); KrasG12D, n = 10 (7 days), n = 3 mice (35 days).
(F) Percentage RFP+ islet cells/total islet cells in Kras WT control and KrasG12D tissues over time. Data represent mean ± SD islets pooled from n = 4
mice/genotype. ***p = 0.0008, non-parametric Student’s t test. Kras WT controls, n = 52 islets (7 days), n = 40 islets (35 days); KrasG12D, n = 33 islets (7 days),
n = 35 islets (35 days).
See also Figures S1 and S2.
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Figure 2. KrasG12D cells are retained in EphA2 knockout tissues
(A) RFP fluorescence in EphA2/ control or KrasG12D/+ EphA2/ tissues. Scale bars, 500 mm.
(B) Percentage of RFP fluorescence/tissue area over time. Each data point represents average RFP fluorescence per mouse. EphA2/ controls, n = 5 (7 days),
n = 6 mice (35 days); KrasG12D EphA2/, n = 4 (7 days), n = 5 mice (35 days).
(C) Percentage of RFP+ ducts in EphA2/ control and KrasG12D EphA2/ tissues at 7 days p.i. EphA2/ control, n = 6 mice; KrasG12D EphA2/, n = 8 mice.
Data are means ± SEMs.
(D) Percentage of RFP+ islet cells/total islet cells in EphA2/ control and KrasG12D EphA2/ tissues over time. Data represent mean ± SD islets pooled from
n = 4mice/genotype at 7 days, n = 6mice/genotype at 35 days. n.s., not significant. **p = 0.0035, non-parametric Student’s t test. EphA2/ controls, n = 49 islets
(7 days), n = 41 (35 days) islets; KrasG12D EphA2/, n = 21 islets (7 days), n = 47 islets (35 days).
(E) Violin plots of internuclear distance (IND, mm) between neighboring RFP+ cells.
(legend continued on next page)
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compared to Kras WT controls (p < 0.0001; Figure 2G). In
contrast, KrasG12D cells no longer formed tightly packed or
round clusters (p < 0.0001; Figures 2E and 2F) and did not
decrease in cell volume (p < 0.0001; Figure 2G) in KrasG12D
EphA2/ tissues.
To further investigate the requirement of EphA2 in driving
these phenotypes, we isolated primary murine pancreatic ductal
epithelial cells (PDECs) and applied established coculture as-
says in vitro.4,10 When mixed with non-transformed PDECs at
1:50 ratios, pre-labeled KrasG12D ductal epithelial cells formed
tightly packed clusters (Figure 3A; KR:N), that significantly
decreased in cell area in a non-autonomous manner (p <
0.0001; Figure 3B; KR:N versus KR:KR). Quantification of the in-
dex of sphericity indicated that clusters of KrasG12D cells were
significantly more roundwhen surrounded by normal cells (KR:N)
compared to KR:KR controls (p < 0.0001; Figure 3C), suggesting
that KrasG12D cells separate from normal neighbors via the for-
mation of smooth boundaries. Crucially, KrasG12D cells
depleted for EphA2 (KRE cells) no longer adopted a contractile
phenotype (Figure 3A; KRE:N), had a significantly higher cluster
area when surrounded by normal cells (p < 0.0001; Figure 3B),
and segregated less efficiently from normal neighbors compared
to KrasG12D cells (p = 0.0052; Figure 3C). We also observed api-
cal extrusion of KrasG12D cells from normal monolayers in an
EphA2-dependent manner (Figure 3D, white arrows). Thus,
EphA2 expressed on KrasG12D cells is required to promote
cell segregation and elimination of KrasG12D pancreatic ductal
epithelial cells in vitro. Our data show that acinar and ductal
epithelial KrasG12D cells shrink and form tightly packed clusters
that separate from normal neighbors in an EphA2-dependent
manner.
KrasG12D cells are outcompeted at normal mutant
boundaries
To gain further insight into how KrasG12D cells are cleared from
tissues, we developed a mathematical model of mutant-normal
cell competition. In the model, mutant cells in direct contact
with normal cells are always outcompeted (Figure S3A). Simula-
tions of competition between mutant and normal cells revealed
that mutant cells are eliminated from the periphery of a mutant
cluster, irrespective of cluster size, leading to an overall
decrease in the size of the cluster (Figure S3A, bottom panels).
In addition, mutant cells are readily eliminated when present in
tissues in low numbers (Figure S3B). The model predicts that
clusters decrease in size by losing 10% of the mutant-normal
cell boundary per day (see STAR methods for details). To
examine experimentally mutant-normal competition at the level
of cluster size, we segmented global RFP fluorescence data to
quantify RFP-labeled clusters in tissues (Figure S3C) and deter-
mined the distribution of clusters based on size. Cluster density
did not significantly change over time in Kras WT tissues (p =
0.28; Figure S3D). In contrast, cluster density significantly
decreased over time in KrasG12D (KC) tissues (p = 0.025;
Figure S3D). Consistently, mathematical modeling of mutant
cluster distribution based on size predicted a decrease in both
cluster density and smaller clusters in 35-day KrasG12D tissues
(Figure S3E). Cluster density did not significantly change
in EphA2/ tissues (Figure S3D). Next, we experimentally
analyzed the distribution of clusters based on size. In contrast
to Kras WT controls (Figure S4A), KrasG12D tissues contained
significantly fewer smaller clusters (of <2,000 mm2) at 35 days
p.i. (Figures S4B and S4E;WT versus KC). In contrast, KrasG12D
EphA2/ (KCE) tissues contained significantly more small clus-
ters at 35 days p.i. compared to KrasG12D tissues at the same
time point (Figures S4C and S4E; KC versus KCE), with a size
distribution of RFP+ clusters in KrasG12D EphA2/ tissues
that is comparable to controls. The distribution of clusters based
on size did not significantly change over time in EphA2/ con-
trols (Figure S4D).
Increased mechanical tension at normal mutant boundaries
may promote the efficient elimination of small clusters.15,33 Im-
munostaining of fixed tissues for F-actin and phosphorylated
myosin light chain (Figure S4F) indicate that the actin-myosin
cytoskeleton is not enriched at KrasG12D-normal boundaries
in vivo, suggesting that KrasG12D cells are unlikely to be elimi-
nated via mechanical tension at cluster boundaries. To control
for the observed changes in acinar cell morphology in vivo (Fig-
ures 2E–2G), we quantified the number of RFP+ acinar cells per
cluster at the single-cell level. This revealed that the number of
RFP+ cells per cluster significantly decreased in KrasG12D
(KC) tissues only, irrespective of cluster size (p = 0.002; Fig-
ure S4G). In contrast, RFP+ cells per cluster significantly
increased in KrasG12D EphA2/ (KCE) tissues (p = 0.017; Fig-
ure S4G). These data support the model and suggest that
competition with normal cells leads to a progressive loss of
mutant cells from all clusters and an overall decrease in cluster
size, in an EphA2-dependent manner.
EphA2 is required to destabilize E-cadherin-based cell-
cell contacts at normal mutant boundaries
We hypothesized that E-cadherin-based cell-cell contacts are
remodeled in vivo in response to a loss of mutant cell volume
and before mutant cell elimination. We immunostained pancreas
tissues fixed at 7 days p.i. for endogenous E-cadherin. Focusing
on acinar and islet compartments, we found that E-cadherin
localizes uniformly at cell-cell contacts in Kras WT tissues (Fig-
ures 4A and 4C; control) but appeared weaker and punctate at
cell-cell contacts in KrasG12D tissues (Figures 4A and 4C).
Quantification of E-cadherin fluorescence at cell-cell contacts
between RFP+ and RFP cells revealed that E-cadherin was
significantly decreased at RFP+/RFP interfaces in acinar (p =
0.0048; Figure 4B) and islet (p = 0.013; Figure 4D) compartments
in KrasG12D tissues compared to Kras WT controls. Similarly,
E-cadherin was predominantly intracellular in KrasG12D ductal
epithelial cells in a non-cell autonomous manner in vitro (Fig-
ure 3E; KR:N). In contrast, E-cadherin was significantly enriched
(F) Circularity of RFP clusters in tissues.
(G) RFP+ cell volume (mm3). Red line, median. Dashed lines, quartiles. **p < 0.01, ****p < 0.0001, non-parametric Kruskal-Wallis ANOVA with post hoc test
comparing KrasG12D to controls and KrasG12D to KrasG12D EphA2/. Data represent values pooled from 3mice (KrasWT controls, KrasG12D EphA2/, and
EphA2/ controls) or 4 mice (KrasG12D). See STAR Methods for n numbers.
See also Figures S2–S4 and Video S1.
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at cell-cell contacts between RFP+ cells and RFP neighbors in
acinar and islet compartments in KrasG12D EphA2/ tissues
compared to KrasG12D (Figures 4A and 4C, p < 0.0001, Figures
4B and 4D), and was uniformly localized at cell-cell contacts
when KRE cells were surrounded by non-transformed cells
in vitro (Figure 3E). Interestingly, E-cadherin fluorescence was
significantly higher at RFP+/RFP boundaries in acinar and islet
compartments in EphA2/ control tissues compared to Kras
WT controls (p < 0.0001; Figures 4B and 4D), suggesting that
EphA2 regulates E-cadherin localization at cell-cell contacts in
a cell-autonomous manner. We speculated that EphA2 may pro-
mote E-cadherin turnover at mutant-normal cell-cell contacts.
We stained tissues fixed at 7 days p.i. for endogenous p120 cat-
enin, which directly binds to the intracellular domain of E-cad-
herin and stabilizes cell-cell adhesion by preventing endocy-
tosis.34 Focusing on exocrine acinar cells, we found that p120




B Figure 3. EphA2 expressed on KrasG12D
cells drives cell segregation and apical extru-
sion of mutant cells from normal tissues
in vitro
(A, D, and E) Transformed tumor-derived epithelial
cells (KR, KrasG12D; KRE, KrasG12D EphA2/)
prelabeled with cell tracker dye (CMRA, red) and
mixed with non-labeled, non-transformed PDECs
(N) (KR:N, KRE:N) or non-labeled transformed cells
(KR:KR, KRE:KRE) at 1:50 ratios. Cells were fixed at
48 h. (A) Images of pancreatic ductal epithelial cell
(PDEC) coculture assays. (D) KrasG12D cells are
apically extruded in an EphA2-dependent manner.
White arrows label apically extruded cells. (A and D)
Gray, F-actin; blue, Hoescht. (E) Cyan, anti-E-cad-
herin antibodies; blue, Hoescht. Scale bars, 20 mm.
(B andC) Scatterplots of (B) transformed cell cluster
area (mm2) in coculture assays and (C) index of
sphericity of normal mutant boundaries. Red lines
denote median. Data represent counts from n = 3
repeats. **p < 0.01, ****p < 0.0001, non-parametric
Kruskal-Wallis ANOVA with post hoc test
comparing KR:N to KR:KR and KR:N to KRE:N. See
STAR Methods for n numbers.
and unlabeled cells in KrasG12D tissues
compared to KrasWT controls (Figure 4E).
Levels of p120 catenin fluorescence
at cell-cell contacts were significantly
lower at RFP+/RFP cell-cell contacts in
KrasG12D tissues compared to Kras WT
controls (p < 0.0001; Figure 4F). In
contrast, p120 catenin fluorescence was
significantly increased at RFP+/RFP
cell-cell contacts in KrasG12D EphA2/
tissues compared to KrasG12D tissues
(Figure 4E, p < 0.0001, Figure 4F), sug-
gesting that EphA2 is required to regulate
E-cadherin turnover at mutant-normal
cell boundaries in vivo. p120 catenin fluo-
rescence was significantly decreased in
EphA2/ tissues compared to WT con-
trols (Figure 4F; p = 0.0046), suggesting
that the regulation of E-cadherin downstream of EphA2 requires
additional regulators.
Normal cells expand to compensate for the loss of
mutant cells
We postulated that the loss of mutant cells from KrasG12D tis-
sues triggers the compensatory expansion of adjacent WT cells
rather than cell proliferation. Using 3D reconstructed tissue data-
sets, we quantified the cell volume of normal acinar cells either
directly adjacent or non-adjacent to RFP+ acinar cells (Figure 5A).
In KrasG12D tissues (KC), normal cells directly adjacent to RFP+
cells had a significantly larger cell volume compared to that of
non-adjacent normal cells (p < 0.0001; Figure 5B), suggesting
that normal cells in direct contact with KrasG12D cells expand
in size. In contrast, the cell volume of normal cells adjacent to
RFP+ cells was not significantly different from that of non-adja-
cent cells in KrasG12D EphA2/ (KCE) tissues (p = 0.46;
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Figure 5C), suggesting that the expansion of normal cells re-
quires functional EphA2.
Loss of EphA2 accelerates early development of
premalignant lesions
Finally, we asked whether the retention of KrasG12D cells in
EphA2 knockout tissues correlates with the development of pre-
malignant lesions. While the majority of KrasG12D cells were
eliminated by 35 days p.i., a small population of KrasG12D cells
consistently remained in KrasG12D tissues (Figures 1B and 1C).
Using Alcian blue staining as a marker of mucin-positive PanIN
lesions,35 we investigated whether the presence of this popula-
tion of KrasG12D cells in tissues could induce PanIN lesion
development. PanIN lesions were rare in KrasG12D (KC) tissues
at 35 days p.i. (Figure 6B; 2/7 mice) but were more frequent at
140 days p.i. (Figures 6A and 6B; 7/9 mice), suggesting that
non-eliminated KrasG12D cells expand to form lesions over pro-
tracted time points. These data are consistent with our previ-
ously reported data22 and suggest that a subpopulation of
KrasG12D cells evades elimination signals to initiate disease.
Strikingly, we observed significantly more mucin-positive PanIN
lesions in KrasG12D EphA2/ (KCE) tissues at 35 days p.i.
compared to KrasG12D tissues at the same time point (p =
0.0029; Figures 6A and 6B; 6/6mice). At 140 days, PanIN density
was comparable in both KrasG12D (KC) and KrasG12D
EphA2/ (KCE) tissues (Figure 6B). We conclude that the loss
of functional EphA2 leads to an increase in the number of
KrasG12D cells retained in tissues, which in turn accelerates





Figure 4. Adherens junctions are remodeled at mutant-normal cell-cell contacts in exocrine and endocrine tissues in an EphA2-dependent
manner
(A, C, and E) Images of exocrine/endocrine tissues from each genotype fixed at 7 days p.i. and stained with anti-RFP (red), anti-E-cadherin (cyan; A and C), or
p120-catenin (gray; D) antibodies and Hoescht (blue). Area in yellow dashed box inmerged image: digital enlarged (‘‘digital zoom’’) image. Scale bars, 20 mm. See
also Video S1.
(B, D, and F) Scatterplots of E-cadherin (B and D) or p120-catenin (F) fluorescence at cell-cell interfaces between RFP+-RFP cells inKrasWT control, KrasG12D,
EphA2/, or KrasG12D EphA2/ tissues. Red bar denotes the mean. Data represent cell-cell contacts pooled from n = 3 mice (Kras WT controls, KrasG12D
EphA2/, EphA2/ controls), n = 4 mice (KrasG12D). See STAR Methods for n numbers. *p < 0.05, **p < 0.005, ****p < 0.0001, non-parametric Kruskal-Wallis
ANOVA with post hoc test comparing KrasG12D to control and KrasG12D to KrasG12D EphA2/, or control to EphA2/.
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DISCUSSION
Here, we show that cells carrying oncogenic KrasG12D muta-
tions are outcompeted by normal cells in adult pancreas
epithelia in vivo. We reveal a novel essential role of EphA2 recep-
tor in this process and show that EphA2 is required to remove
KrasG12D cells from exocrine acinar, duct, and endocrine com-
partments in vivo. The elimination of KrasG12D cells from each
compartment occurs over different timescales, suggesting that
different processes may be required to remove KrasG12D cells,
depending on tissue location (e.g., local tissue architecture [i.e.,
a single layer of ductal epithelial cells versus a 3D acinus or islet]
and/or EphA2/ephrin A expression). In the absence of functional
EphA2, KrasG12D cells are retained and the density of PanIN
lesions in tissues increases. Thus, EphA2 is required to maintain
pancreas tissue health by promoting the elimination of
KrasG12D cells, with the retention of mutant cells accelerating
tumor initiation. Our data add to the growing body of evi-
dence7,36–38 demonstrating an innate ability of epithelial tissues
to prevent tumor initiation following mutational insult.
Eph-ephrin biology in the pancreas is incompletely under-
stood. Both A and B Ephs and ephrins are expressed in the
developing pancreas,39 and EphB signals regulate pancreas tis-
sue branching, morphogenesis,40 and cell fate decisions.41 In
adult tissues, EphA-ephrinA signals regulate insulin secretion;42
however, the role of Eph-ephrin signaling in exocrine tissues is
less clear. Eph-ephrins were originally identified as neural guid-
ance molecules that play a crucial role in neurogenesis. Intrigu-
ingly, other guidance molecules have been implicated in cell
competition in epithelial tissues. In Drosophila melanogaster,
Slit-Robo signals drive the extrusion of polarity-deficient cells
by disrupting E-cadherin,43 while semaphorin-plexin signaling
promotes the elimination of damaged cells during epithelial
wound repair.44 We have previously shown in Drosophila
melanogaster that DEph is required to eliminate RasV12 cells
from developing epithelia.10 Taken together with our current
A
B C
Figure 5. Normal cells directly neighboring
KrasG12D cells increase in cell volume in vivo
in an EphA2-dependent manner
(A) Pancreas tissue fixed at 7 days p.i. and stained
with anti-RFP (red), anti-E-cadherin (green) anti-
bodies, and Hoescht (blue). Segmentation analysis in
3D labels normal cells (pseudo-colored) neighboring
RFP+ mutant cells (dashed line). Scale bar, 20 mm.
(B and C) Cell volume (mm3) of RFP+ and unlabeled
normal cells, adjacent or non-adjacent to RFP+ cells
in (B) KrasG12D (KC) and (C) KrasG12D EphA2/
(KCE) tissues. Red line, median; dashed lines, quar-
tiles. n.s., not significant. ****p < 0.0001, non-para-
metric Student’s t tests. Data represent volume of
individual cells pooled from n = 3 mice KrasG12D
EphA2/ (KCE); n = 4 mice KrasG12D (KC). See
STAR Methods for n numbers.
See also Video S1.
evidence, these observations suggest that
cell-cell communication signals have impor-
tant functions inmaintaining epithelial tissue
health and homeostasis.
In general, cell competition induces apoptosis of unfit cells
and cell proliferation in surrounding cells, thus ensuring that
overall tissue size is maintained.45 In the pancreas, apoptotic
events are rare, and we found no evidence of the compensatory
proliferation of normal cells, suggesting that KrasG12D cell
competition does not require the activation of canonical compe-
tition signals. However, the targeted inhibition of caspase activity
in vivo would definitively determine whether mutant cells are
eliminated from adult pancreas tissues via apoptosis-dependent
signaling. In D. melanogaster, cell competition can induce the
rapid expansion of ‘‘winner’’ cells immediately neighboring
‘‘loser’’ cells, independent of cell proliferation.46,47 We observe
similar phenomena in pancreas tissues in vivo: normal cells
neighboring KrasG12D cells expand in cell size in response to
mutant cells losing cell volume. Mutant and normal cell volumes
are not altered in the absence of functional EphA2. Future
studies are required to determine the mechanisms underlying
how KrasG12D/normal cells lose/gain volume in vivo and how
EphA2 is contributing to this process.
Our findings imply that EphA2 is a novel tumor suppressor in
pancreatic cancer, with the loss of function promoting rapid
development of premalignant lesions. Interestingly, loss of
EphA2 cooperates with RAS mutations to drive skin48 and
lung49 tumorigenesis. Whether EphA2 is required to clear RAS
mutant cells and preserve tissue health in other epithelial tissues
remains to be investigated. Paradoxically, EphA2 is upregulated
at the protein level in KRAS-driven tumors50–52 and is a transcrip-
tional target of RAS-mitogen-activated protein kinase (MAPK)
signaling in vitro.10,53 Mouse studies indicate that the loss of
EphA2 is not essential for primary PDAC tumor development,
but it is required for metastasis.54 In human tumors, EphA2
expression negatively correlates with PanIN lesions but
increases in metastatic tumors;55 however, EphA2 is rarely
genetically altered in human tumors,55 suggesting that protein
expression and/or stability is deregulated during tumorigenesis.
We propose that tissue context is pivotal to understanding the
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different roles of EphA2 in tumor biology. Specifically, activation
of canonical EphA2 signaling within the context of ephrin
ligand-expressing neighbors would drive compartmentalization
and expulsion of mutant cells10,56 (and the concomitant
degradation of EphA2 protein57). In the absence of ligand-
expressing neighbors (e.g., EphA2-expressing KRAS-driven
tumors), non-canonical signaling of EphA2 would promote
metastasis.54,58,59
Considering that KRAS mutations drive all stages of pancre-
atic cancer60 (with codon 12 being the most prevalent, detected
in >80% of human tumors20), our data imply that KrasG12D
mutant cells must be able to override competitive signals to sur-
vive in tissues and initiate tumorigenesis in patients. Our study
also reveals that a population of KrasG12D cells are never elim-
inated and go on to initiate and drive premalignant lesion devel-
opment. Future work is required to determine the mechanisms
underlying how rare KrasG12D cells evade competition with
normal cells to survive in tissues. A better understanding of the
mechanisms by which normal cells outcompete KrasG12D cells
could lead to therapies to alter the fitness landscape,14 promot-
ing elimination of aberrant cells and decreasing pancreatic can-
cer incidence. Understanding the mechanisms underlying how
KrasG12D cells increase fitness could provide novel insights
into how risk factors drive disease.
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Jülicher, F., Salbreux, G., and Classen, A.K. (2016). Interface contractility
between differently fated cells drives cell elimination and cyst formation.
Curr. Biol. 26, 563–574.
34. Nanes, B.A., Chiasson-MacKenzie, C., Lowery, A.M., Ishiyama, N.,
Faundez, V., Ikura, M., Vincent, P.A., and Kowalczyk, A.P. (2012). p120-
catenin binding masks an endocytic signal conserved in classical cadher-
ins. J. Cell Biol. 199, 365–380.
35. Krah, N.M., De LaO, J.P., Swift, G.H., Hoang, C.Q., Willet, S.G., Chen Pan,
F., Cash, G.M., Bronner, M.P., Wright, C.V., MacDonald, R.J., and
Murtaugh, L.C. (2015). The acinar differentiation determinant PTF1A in-
hibits initiation of pancreatic ductal adenocarcinoma. eLife 4, e07125.
36. Merino, M.M., Rhiner, C., Lopez-Gay, J.M., Buechel, D., Hauert, B., and
Moreno, E. (2015). Elimination of unfit cells maintains tissue health and
prolongs lifespan. Cell 160, 461–476.
37. Martins, V.C., Busch, K., Juraeva, D., Blum, C., Ludwig, C., Rasche, V.,
Lasitschka, F., Mastitsky, S.E., Brors, B., Hielscher, T., et al. (2014). Cell
competition is a tumour suppressor mechanism in the thymus. Nature
509, 465–470.
38. Ellis, S.J., Gomez, N.C., Levorse, J., Mertz, A.F., Ge, Y., and Fuchs, E.
(2019). Distinct modes of cell competition shape mammalian tissue
morphogenesis. Nature 569, 497–502.
39. van Eyll, J.M., Passante, L., Pierreux, C.E., Lemaigre, F.P.,
Vanderhaeghen, P., and Rousseau, G.G. (2006). Eph receptors and their
ephrin ligands are expressed in developing mouse pancreas. Gene
Expr. Patterns 6, 353–359.
ll
OPEN ACCESS
10 Current Biology 31, 1–11, June 21, 2021
Please cite this article in press as: Hill et al., EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult
pancreas, Current Biology (2021), https://doi.org/10.1016/j.cub.2021.03.094
Article
40. Villasenor, A., Chong, D.C., Henkemeyer, M., and Cleaver, O. (2010).
Epithelial dynamics of pancreatic branching morphogenesis.
Development 137, 4295–4305.
41. Villasenor, A., Marty-Santos, L., Dravis, C., Fletcher, P., Henkemeyer, M.,
and Cleaver, O. (2012). EphB3 marks delaminating endocrine progenitor
cells in the developing pancreas. Dev. Dyn. 241, 1008–1019.
42. Konstantinova, I., Nikolova, G., Ohara-Imaizumi, M., Meda, P., Kucera, T.,
Zarbalis, K., Wurst, W., Nagamatsu, S., and Lammert, E. (2007). EphA-
Ephrin-A-mediated beta cell communication regulates insulin secretion
from pancreatic islets. Cell 129, 359–370.
43. Vaughen, J., and Igaki, T. (2016). Slit-robo repulsive signaling extrudes
tumorigenic cells from epithelia. Dev. Cell 39, 683–695.
44. Yoo, S.K., Pascoe, H.G., Pereira, T., Kondo, S., Jacinto, A., Zhang, X., and
Hariharan, I.K. (2016). Plexins function in epithelial repair in both
Drosophila and zebrafish. Nat. Commun. 7, 12282.
45. Bowling, S., Lawlor, K., and Rodrı́guez, T.A. (2019). Cell competition: the
winners and losers of fitness selection. Development 146, dev167486.
46. Tsuboi, A., Ohsawa, S., Umetsu, D., Sando, Y., Kuranaga, E., Igaki, T., and
Fujimoto, K. (2018). Competition for space is controlled by apoptosis-
induced change of local epithelial topology. Curr. Biol. 28, 2115–2128.e5.
47. Tamori, Y., and Deng, W.M. (2013). Tissue repair through cell competition
and compensatory cellular hypertrophy in postmitotic epithelia. Dev. Cell
25, 350–363.
48. Guo, H., Miao, H., Gerber, L., Singh, J., Denning, M.F., Gilliam, A.C., and
Wang, B. (2006). Disruption of EphA2 receptor tyrosine kinase leads to
increased susceptibility to carcinogenesis in mouse skin. Cancer Res.
66, 7050–7058.
49. Yeddula, N., Xia, Y., Ke, E., Beumer, J., and Verma, I.M. (2015). Screening
for tumor suppressors: loss of ephrin receptor A2 cooperates with onco-
genic KRas in promoting lung adenocarcinoma. Proc. Natl. Acad. Sci.
USA 112, E6476–E6485.
50. Brubaker, D.K., Paulo, J.A., Sheth, S., Poulin, E.J., Popow, O., Joughin,
B.A., Strasser, S.D., Starchenko, A., Gygi, S.P., Lauffenburger, D.A., and
Haigis, K.M. (2019). Proteogenomic network analysis of context-specific
KRAS signaling in mouse-to-human cross-species translation. Cell Syst.
9, 258–270.e6.
51. Sudhir, P.R., Chen, C.H., Pavana Kumari, M., Wang, M.J., Tsou, C.C.,
Sung, T.Y., Chen, J.Y., and Chen, C.H. (2012). Label-free quantitative pro-
teomics and N-glycoproteomics analysis of KRAS-activated human bron-
chial epithelial cells. Mol. Cell. Proteomics 11, 901–915.
52. Yao, W., Rose, J.L., Wang,W., Seth, S., Jiang, H., Taguchi, A., Liu, J., Yan,
L., Kapoor, A., Hou, P., et al. (2019). Syndecan 1 is a critical mediator of
macropinocytosis in pancreatic cancer. Nature 568, 410–414.
53. Macrae, M., Neve, R.M., Rodriguez-Viciana, P., Haqq, C., Yeh, J., Chen,
C., Gray, J.W., and McCormick, F. (2005). A conditional feedback loop
regulates Ras activity through EphA2. Cancer Cell 8, 111–118.
54. Gundry, C., Marco, S., Rainero, E., Miller, B., Dornier, E., Mitchell, L.,
Caswell, P.T., Campbell, A.D., Hogeweg, A., Sansom, O.J., et al. (2017).
Phosphorylation of Rab-coupling protein by LMTK3 controls Rab14-
dependent EphA2 trafficking to promote cell:cell repulsion. Nat.
Commun. 8, 14646.
55. Mudali, S.V., Fu, B., Lakkur, S.S., Luo, M., Embuscado, E.E., and
Iacobuzio-Donahue, C.A. (2006). Patterns of EphA2 protein expression
in primary and metastatic pancreatic carcinoma and correlation with ge-
netic status. Clin. Exp. Metastasis 23, 357–365.
56. Cortina, C., Palomo-Ponce, S., Iglesias, M., Fernández-Masip, J.L.,
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse anti-E-cadherin BD Transduction laboratories Cat#610182; RRID: AB-397581
Mouse anti-p120-catenin BD Transduction laboratories Cat#612537; RRID: AB_399834
Rabbit anti-RFP Creative Diagnostics, Rockland Cat#H8319; RRID: AB_2428646;
Cat#600401-379; RRID: AB_2209751
Rabbit anti-ki67 Abcam Cat#ab16667; RRID: AB_302459
Rabbit anti-cleaved caspase 3 Cell Signaling Technology Cat#9661; RRID: AB_2341188
Rabbit anti- phosphorylated myosin light chain 2
(Thr18/Ser19)
Cell Signaling Technology Cat#3674; RRID: AB_2147464
Chemicals, peptides, and recombinant proteins
Tamoxifen Sigma-Aldrich/Merck T5648
Phalloidin Sigma-Aldrich/Merck Atto 647N 65906
Cholera toxin Sigma-Aldrich/Merck C8052
Bovine pituitary extract Corning 354123
3,3,5-tri-iodo-L-thyronine Sigma-Aldrich/Merck T0281
Epidermal growth factor (EGF) mouse Corning 354001
Nicotinamide Sigma-Aldrich/Merck N3376
Dexamethasone Sigma-Aldrich/Merck D4902
Butyl-methyl methacrylate plastic (BMMA)









TUNEL assay Abcam Ab66110
DNAeasy blood and tissue kit QIAGEN 56304
SyGreen qPCR kit PCR Biosystems PB20.11-05
Experimental models: cell lines




Mouse: Tg(Pdx1-cre/Esr1*)#Dam 61 The Jackson Laboratory 024968
Mouse: Kras < tm4Tyj 62 The Jackson Laboratory 008179
Mouse: Gt(ROSA)26Sor < tm1Hjf 63 MGI #3696099
Mouse: Epha2tm1Jrui 29 The Jackson Laboratory 006028
Oligonucleotides
Genotyping primer. Kras universal CCT TTA CAA
GCG CAC GCA GAC TGT AGA
This paper N/A
Genotyping primer. Kras Mutant AGC TAG CCA
CCA TGG CTT GAG TAA GTC TGC A
This paper N/A
Genotyping primer. Kras wild type GTC GAC
AAG CTC ATG CGG GTG
This paper N/A
Genotyping primer. ROSA RFP Forward
AAG GGA GCT GCA GTG GAG TA
64 https://doi.org/10.1523/JNEUROSCI.4303-11.2012
Genotyping primer. ROSA RFP reverse AAG ACC
GCG AAG AGT TTG TCC
64 https://doi.org/10.1523/JNEUROSCI.4303-11.2012
Genotyping primer. RFP Wild type reverse TAA
GCC TGC CCA GAA GAC TCC
64 https://doi.org/10.1523/JNEUROSCI.4303-11.2012
(Continued on next page)
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Catherine
Hogan (HoganC@cardiff.ac.uk).
Materials availability
This study did not generate new unique reagents.
Data and code availability
The code generated during this study are available on the GitHub platform (https://github.com/ThomasEWoolley/KRASG12D).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse models and primary cell culture
Pdx1-CreERT[61], LSL-KrasG12D/+[62], Rosa26LSL-tdRFP[63] and Epha2/[29] mouse lines have all been previously described. Animals
were housed in conventional pathogen-free animal facilities and experiments were conducted in accordance with UK Home Office
regulations (ASPA 1986 & EU Directive 2010) under the guidelines of Cardiff University Animal Welfare and Ethics Committee. Mice
were genotyped by PCR analysis following standard methods. Primer sequences64,65 are detailed in the Key resources table.
Isolation of transformed mouse pancreatic cells was performed as previously described.22 Transformed cells were maintained in
Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% FBS and 1% penicillin/streptomycin. Normal primary ductal
epithelial cells were isolated from pancreata harvested from adult mice of both sexes, as described previously.67 Briefly, whole
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Genotyping primer. EphA2 Common TGT CAC
TTG CGA ACA GTG CT
The Jackson Laboratory https://www.jax.org/Protocol?stockNumber=
006028&protocolID=27262
Genotyping primer. EphA2 Mutant reverse GTG
GAG AGG CTT TTT GCT TC
The Jackson Laboratory https://www.jax.org/Protocol?stockNumber=
006028&protocolID=27262
Genotyping primer. EphA2 Wild type reverse
CGC TAT CAC ACT CAG CAG GA
The Jackson Laboratory https://www.jax.org/Protocol?stockNumber=
006028&protocolID=27262
Genotyping primers. Pdx-1 Cre Forward:
CTG GAC TAC ATC TTG AGT TGC. Reverse:
GGT GTA CGG TCA GTA AAT TTG
65 https://doi.org/10.1172/JCI65764
Kras recombined. Forward: GTC TTT CCC
CAG CAC AGT GC. Reverse: CTC TTG CCT
ACG CCA CCA GCT and AGC TAG CCA CCA
TGG CTT GAG TAA GTC TGC
This paper N/A
RFP recombined. Forward: CAA ACT CTT
CGC GGT CTT TC. Reverse: CAC CTT GAA
GCG CAT GAA CT
This paper N/A
ApoB. Forward: CAC GTG GGC TCC AGC ATT.




Imaris for Cell biologists 8.0 Bitplane https://imaris.oxinst.com/
MATLAB code used in mathematical model This paper https://github.com/ThomasEWoolley/KRASG12D





Zeiss ZEN blue Zeiss https://www.zeiss.com/microscopy/int/
products/microscope-software.html
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pancreas was mechanically dissociated before digestion in collagenase at 37C. Following several washes in HBSS supplemented
with 5% FBS, tissue was passed through a 40 mm cell strainer. Cells were then digested with trypsin for 5 min before washing to
remove any trace of collagenase. The washed cells were then resuspended in PDEC medium (DMEM/F12 with 5% Nu-Serum,
5 mg/ml glucose, 1.22 mg/ml nicotinamide, 0.1 mg/ml soybean trypsin inhibitor, 25 mg/ml bovine pituitary extract, 20 ng/ml EGF,
100 ng/ml cholera toxin, 5 nM 3,3,5-tri-iodo-L-thyronine, 5 mL/L ITS+ culture supplement, 1 mM dexamethasone). Cells were plated
on rat collagen I- (Corning) coated 6-well plates.
METHOD DETAILS
Induction of Cre recombinase in vivo
Both male and female experimental and control animals were injected at 6-8 weeks of age by intraperitoneal injection of tamoxifen in
corn oil. Low frequency expression of RFP was induced via a single intraperitoneal injection of 1 mg/40 g bodyweight (low dose) with
widespread recombination (high dose) induced by three injections of 9 mg/40 g over 5 days.24 At specified time points the pancreas
was harvested and routinely dissected into three segments. Segments were then either fixed in 10% neutral buffered formalin (Sigma
Aldrich) overnight at 4C for IHC/IF, snap frozen in OCT or fixed in 2% paraformaldehyde for immunofluorescence tomography. No
statistical method was used to pre-determine sample size. For animal studies, experiments were not randomized, and investigators
were not blinded to allocation during experiments. All experiments were reproduced with at least three independent experiments and
at least three animals of each genotype.
Scoring RFP in tissues
To measure global levels of endogenous RFP fluorescence, five 10 mm thick cryosections were cut from fresh frozen tissues with
each slice at least 50 mm apart and immediately imaged. Whole sections were imaged on a Zeiss confocal LSM 710 using tile scans
for brightfield and RFP. RFP fluorescence was averaged from five tissue slices (of 50 mm apart) per mouse. Global endogenous RFP
fluorescence was calculated as a proportion of total tissue area. Tissue area was quantified from brightfield images and RFP fluo-
rescence was segmented and measured using ImageJ. For cluster analysis, clusters were discretely segmented and quantified in
ImageJ and binned on size before normalizing to total tissue area. This produced a density of clusters of different sizes which
was plotted in GraphPad. RFP positive ducts and RFP positive acinar cells were scored in tissues fixed and stained using immuno-
fluorescence tomography protocols (described below). RFP positive islets were scored in formalin-fixed paraffin-embedded (FFPE)
tissues and immunohistochemistry protocols (described below). Recombined RFP in genomic DNA (gDNA) was measured by qPCR
(SyGreen mix; PCR Biosystems) and primer sets (Key resources table). gDNA extraction was carried out from tissues using the
DNeasy genomic DNA kit (QIAGEN) following the manufacturer’s instructions. Levels of recombined RFP allele relative to ApoB
were analyzed by the delta Ct method.
Tissue staining by immunohistochemistry
Histological staining was performed on FFPE sections. For RFP IHC, tissue was fixed in 10% neutral buffered formalin (Sigma-
Aldrich) for 24 h at 4C. Formalin was replaced by 70% ethanol and tissue was processed into wax blocks by standard methods.
Sections were cut at 5 mm thickness, dewaxed and rehydrated. For antigen retrieval, tissue sections were incubated in 20 mg/ml
Proteinase K (Roche) diluted in TBS/T for 15 min at 37C. Sections were blocked in 3% H2O2 (Sigma Aldrich) for 20 min, followed
by 5% Normal Goat Serum (NGS) (S-1000, Vector Labs) for 30 min. Anti-RFP (Rabbit, polyclonal) antibody (Rockland) was used
at 1:500. Incubation with the primary antibody was performed overnight at 4C. Secondary antibody ImmPRESS goat anti-Rabbit
(MP-7451, Vector Labs) was added at room temperature for 30 min followed by DAB chromogen (Peroxidase substrate kit: SK-
4100, Vector Labs) for 3 min. For cleaved caspase 3 and Ki67 IHC, samples were washed in xylene before rehydration in decreasing
concentrations of ethanol. After washing, antigen retrieval was carried out using citrate buffer (10mM, pH 6.0) and boiling in a pres-
sure cooker for 5 min (Ki67) or 8 min (CC3). Endogenous peroxidase was blocked by incubation in 0.5%H2O2 for 20 min (Ki67) or 3%
H2O2 for 10min (CC3). Sections were blocked in 20%NGS for 30min (Ki67) or 5%NGS for 60 min (CC3) before incubation in primary
antibody overnight (anti-Ki67, 1:50; anti-cleaved Caspase 3, 1:200). Following washing, samples were incubated with biotinylated
secondaries (E0432, DAKO) before visualization using Vectastain ABC kit (PK-6100, Vector Lab) and counterstained with DAB.
IHC stained tissues were scanned using the Axio Scan Z1 slide scanner (Zeiss, Cambridge, UK), using a 20X magnification, and im-
ages were analyzed using the Zeiss Axio Scan Zen software. Quantification of IHC (cells positive for antibody staining, or proportion
of RFP positive islet cells) was carried out manually using Zeiss Zen software. RFP positive islets were scored from four tissue sec-
tions (50 mm apart) per mouse, n = 4-6 animals/genotype.
For Alcian Blue staining, FFPE tissue sections were dewaxed in xylene and rehydrated in decreasing concentrations of ethanol,
before washing in 3% acetic acid for 5 min. Tissue sections were incubated in staining solution (1% Alcian Blue in 3% acetic acid
pH 2.5) for 10 min, before extensively washed in 3% acetic acid. Following water rinsing, tissue sections were counterstained using
Nuclear Fast Red solution for 10min (N3020, Sigma, Nuclear Fast Red: 0.1% in 5%aluminum sulfate). Following staining, specimens
were rinsed in water, dehydrated and equilibrated into xylene, and mounted with DPX mountant. The entire tissue area was imaged
on a Zeiss Axio Scan Z1 slide scanner followed by surface area measurement using Zeiss ZEN software. Alcian Blue positive PanIN
lesions per mm2 surface area were counted manually.
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Tissue staining by immunofluorescence
TUNEL staining was carried out on FFPE tissues using a commercially available kit (Abcam) according to themanufacturer’s protocol
and Hoescht 33342. Stained tissues were imaged using a Leica DMI600B inverted epifluorescence microscope. For F-actin and
phosphorylated myosin light chain (p-MLC) staining, tissue was fixed in 10% neutral buffered formalin overnight at 4C, washed
in PBS and embedded in OCT. Sections of 50 mm were first defrosted at room temperature overnight, washed in PBS and PBS-T
(0.03% Triton x100). Sections were blocked with PBS-T 10% FBS over 60 min at room temperature, followed by incubation with
primary antibody (rabbit anti-p-MLC; 1:200) or phalloidin (1:1000, Sigma-Aldrich) and Hoescht 33342 solution for 1 h at room
temperature. After washing with PBS-T, sections were mounted in Mowiol.
Immunofluorescence tomography (IT)
Immunofluorescence tomography (IT) is a high-resolution 3D reconstruction method based on embedding in methacrylate followed by
serial sectioning.32 Computational alignment of 2D immunostained serial sections produces a 3D volume rendering andwas carried out
as previously described.31,32 Briefly, fixed tissuewas embedded in butyl-methylmethacrylate plastic (BMMA) under UV following dehy-
dration and resin infiltration. Serial 2 mm-thick sections were then rehydrated, and antigens unmasked by boiling in citrate buffer for at
least 7min. Sampleswere blocked in 5%NGSbefore incubation in primary antibody overnight at 4C. Primary antibodies are detailed in
Key resources table and were used at 1:500 dilutions. After three PBS washes, samples were incubated for two hours at room temper-
ature in appropriate secondary antibodies (1:200; Life Technologies) before washing, staining nuclei with Hoescht 33342 andmounting
in Mowiol. Individual sections were then imaged and aligned semi-automatically using Amira (Version 5.4). See Video S1.
Pancreatic ductal epithelial cell (PDEC) co-culture assays
Cell-cell mixing experiments and staining of cells was carried out as described previously.4,10 In brief, one cell population was labeled
with CMRA cell tracker dye (ThermoFisher Scientific) as previously described,4 beforemixing with unlabelled cells at 1:50 ratios. After
48 hours, cells were fixed in 4% PFA for 15 min, before 15 min permeabilization in 0.25% Triton X-100/PBS and blocking in 3%BSA/
PBS for 1 hour. Cells were then incubated in anti-E-cadherin antibody (Key resources table), diluted in blocking buffer, overnight at
4C. The following day, cells were washed three times with PBS and incubated in secondary antibodies (1:200, Life Technologies)
and phalloidin (1:200) for 1 h at room temperature. Cells were then mounted in Mowiol and imaged on a Zeiss confocal LSM 710.
Mathematical model
We consider two spatial populations denoted by m for mutant and w for wild-type. These two populations interact on a square
based grid, so each point is inhabited by at most one tissue type and the position can be specified by a discrete lattice
coordinate system.68–70 Namely, each lattice site is a square of length d and the ði; jÞth lattice site is either occupied by a wild-type
tissue (i.e., mði; jÞ = 0;wði; jÞ = 1) or a mutant tissue type (i.e., mði; jÞ = 1;wði; jÞ = 0). Whenever a mutant cell is next to a wild-type
cell the two cell types compete, with the wild-type cell winning at a rate d. Critically, we only consider two cells as neighbors if
they share a boundary. Thus, the cells only interact with their north, east, south and west neighbors (Figure S3A).
By considering a general spatial site ði; jÞwewrite down all possible combinations of actions that can occur at that site. Specifically,
mðid; jdÞ+wðði + 1Þd; jdÞ/d wðid; jdÞ+wðði + 1Þd; jdÞ;
mðid; jdÞ+wðði  1Þd; jÞ/d wðid; jdÞ+wðði  1Þd; jdÞ;
mðid; jdÞ+wðid; ðj + 1ÞdÞ/d wðid; jdÞ+wðid; ðj + 1ÞdÞ;
mðid; jdÞ+wðid; ðj  1ÞdÞ/d wðid; jdÞ+wðid; ðj  1ÞdÞ:
The original interaction equations are simulated using a standard ‘‘Gillespie’’ Stochastic Simulation Algorithm (SSA).71–73 To use a
SSA we first need to calculate the propensity, ar , of each reaction, r, where the propensity is the probability per unit time that a spe-





The SSA proceeds as follows:
1. Define the initial time, t = 0, and the final time, tf ; over which we wish to run the algorithm.
2. Generate two uniformly randomly distributed numbers, r1and r2, from the interval [0, 1].
3. Calculate all propensity functions, ar , and their sum a0.










and update the current time, t : = t + t:
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and update the populations based on the reaction that fires.
6. If tRtf then end the simulation, otherwise go to step 2.
This algorithm allows us to accurately simulate a single stochastic trajectory with the correct probabilistic properties. Simulating
multiple trajectories allows us to produce probability distributions that provide us with the probability of the system inhabiting a given
state at a given time.
To compare the simulationswith the data an initial distribution ofmutant patches is needed. Once this has been set the patches can
be numerically simulated, so that future patch sizes can be predicted. The power law behind the seven-day density-area curve is
extracted using a nonlinear least-squares fit algorithm from MATLAB R2019a curve fitting toolbox. Specifically, a curve of the
form y = axb is fitted to the seven-day data from which we obtain the parameter estimates of a= 2436ð95% CI 23822491Þ
and b =  1:067ð95% CI  1:071--  1:063Þ. Upon fixing d= 1mm several different mutant patch sizes are simulated with densities
provided by the power law. Namely, if the area of a patch is x then its density was y. During a simulation, themutant patch sizes shrink
as themutant cells are out competed by the wild-type cells. The simulations are all run for a time, t = 35 days, and the competition rate
d was chosen such that the final simulated curve provided a nonlinear least-squares best fit to the 35-day data.
QUANTIFICATION AND STATISTICAL ANALYSIS
Image analysis
Inter-nuclear distance (IND) was calculated by measuring the distance between the center of nuclei of neighboring cells in 3D pro-
jections using Imaris (Bitplane, Version 8.0). Nuclei were initially segmented using ‘spots’ before measuring from the center of each
spot. To measure cluster area and cell volume, cells were first segmented using Amira. To measure cluster area, index of sphericity
and circularity score, clusters were manually segmented using Fiji66 (ImageJ, Version 2.0) and calculated as previously described.10
Quantification of fluorescent signal for E-cadherin and p120 catenin regions of interest was carried out in ImageJ. Images were taken
under the same exposure time and settings and the mean signal intensity was measured
Statistical tests
Statistical analyses were performed usingGraphPad Prism (v8.0). Normally distributed data, as determined by the Shapiro-Wilke test
were analyzed using unpaired Student’s t tests with Welch correction. Data that were not normally distributed were compared using
non-parametric Mann Whitney U two-tailed t tests. To compare more than two groups, we used ANOVA (Kruskal-Wallis) tests. Post
hoc (Dunn’s multiple comparisons) tests were performed to determine statistical significance between groups. Specifically, we
compared data from KrasG12D tissues to Control, and to KrasG12D EphA2/ tissues. Where relevant, comparisons were also
made between Controls and EphA2/ data. A p value of < 0.05 was taken as significant. No statistical method was used to
pre-determine sample size. Definition of n defined in the figure legends. Also, Figure 2: (E) Kras wild-type control: n = 184 cells;
KrasG12D: n = 218 cells; EphA2/ controls: n = 78 cells; KrasG12D EphA2/: n = 162 cells. (F) Kras wild-type control: n =
102 clusters; KrasG12D: n = 104 clusters; EphA2/ controls: n = 78 clusters; KrasG12D EphA2/: n = 90 clusters. (G) Kras
wild-type control: n = 87 cells; KrasG12D: n = 89 cells; EphA2/ controls: n = 60 cells; KrasG12D EphA2/: n = 113 cells. Figure 3:
(B) KR:KR: n = 23; KR:N: n = 36; KRE:N: n = 23; KRE:KRE: n = 24 clusters. (C) KR:KR: n = 23; KR:N: n = 36; KRE:N: n = 24; KRE:KRE:
n = 22 clusters. Figure 4: Data represent cell-cell contacts pooled from n = 3 mice (Kras wild-type controls, KrasG12D EphA2/,
EphA2/ controls), n = 4 mice (KrasG12D). (B) Control: n = 111; KrasG12D: n = 106; EphA2/ control: n = 98; KrasG12D
EphA2/: n = 96. (D) Control: n = 152; KrasG12D: n = 100; EphA2/ control: n = 90; KrasG12D EphA2-/: n = 138. (F) Data repre-
sent cell-cell contacts pooled from 3 mice/genotype. Control: n = 92; KrasG12D: n = 111; EphA2/ control: n = 96; KrasG12D
EphA2/: n = 93. Figure 5: Data represent volume of individual cells pooled from n = 3 mice KrasG12D EphA2/ (KCE); n = 4
mice KrasG12D (KC). KrasG12D (KC) tissues: n = 101 RFP positive, n = 91 adjacent normal, n = 84 non-adjacent normal. KrasG12D
EphA2/ (KCE): n = 113 RFP positive, n = 61 adjacent normal, n = 61 non-adjacent normal.
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